Company Filing History:
Years Active: 2019
Title: Innovations of Kai-Ho Fok in T1 Mapping Technology
Introduction
Kai-Ho Fok is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of medical imaging, particularly in T1 mapping technology. His innovative approach has the potential to enhance the accuracy and efficiency of magnetic resonance imaging (MRI) techniques.
Latest Patents
Kai-Ho Fok holds a patent for a method titled "Method for T1 mapping with incomplete tissue magnetization recovery." This patent describes methods and systems for performing T1 mapping, where T1 samples are obtained from an acquisition that includes one or more inversion groupings. The acquisition is designed to result in incomplete tissue magnetization recovery between inversion groupings. Additionally, it may utilize non-uniform, non-180° preparatory pulses. The method also incorporates the combined use of data from different inversion groupings, employing a model in which fit parameters are variable dependent on the inversion grouping. This patent showcases his innovative approach to improving MRI technology.
Career Highlights
Kai-Ho Fok is affiliated with the University Health Network, where he applies his expertise in medical imaging. His work focuses on advancing techniques that can lead to better diagnostic outcomes in healthcare. His contributions to the field have been recognized for their potential impact on patient care.
Collaborations
Throughout his career, Kai-Ho Fok has collaborated with esteemed colleagues, including Marshall Stephen Sussman and Bernd Juergen Wintersperger. These collaborations have fostered an environment of innovation and have contributed to the development of advanced imaging techniques.
Conclusion
Kai-Ho Fok's work in T1 mapping technology represents a significant advancement in medical imaging. His innovative methods have the potential to improve diagnostic accuracy and patient outcomes in healthcare. His contributions to the field are noteworthy and reflect his commitment to advancing medical technology.